SEATTLE, July 11, 2023 NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United States District Court for the District of Delaware in NanoString’s patent litigation with 10x Genomics and President and Fellows of Harvard College. In its order, the Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirm
10x and Harvard now must defend against allegations that they "are pursuing an ill-gotten monopoly by enforcing patents that are subject to a requirement that they be licensed non-exclusively" NanoString Technologies,